Cargando…
Patient-Reported Experience and Outcome Measures in People Living with Diabetes: A Scoping Review of Instruments
BACKGROUND: Diabetes mellitus is a global public health concern, with over 463 million people living with this chronic disease. Pathology complexity, management difficulty, and limited participation in care has resulted in healthcare systems seeking new strategies to engage people living with diabet...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8563512/ https://www.ncbi.nlm.nih.gov/pubmed/34043215 http://dx.doi.org/10.1007/s40271-021-00526-y |
_version_ | 1784593419444682752 |
---|---|
author | Martin-Delgado, Jimmy Guilabert, Mercedes Mira-Solves, José |
author_facet | Martin-Delgado, Jimmy Guilabert, Mercedes Mira-Solves, José |
author_sort | Martin-Delgado, Jimmy |
collection | PubMed |
description | BACKGROUND: Diabetes mellitus is a global public health concern, with over 463 million people living with this chronic disease. Pathology complexity, management difficulty, and limited participation in care has resulted in healthcare systems seeking new strategies to engage people living with diabetes. Patient-reported experience measures (PREMs) and patient-reported outcome measures (PROMs) were developed to address the gap between the healthcare system expectation and patient preference. OBJECTIVE: This study aimed to review the existing literature on PREMs and PROMs specific to type 1 and 2 diabetes, and report the dimensions report the dimensions they have measured. METHODS: A scoping review was conducted from January 1985 to March 2020 of six databases, MEDLINE, EMBASE, PsycINFO, CINHAL, Scopus, and BiblioPro, to identify PREM and PROM instruments specific for type 1 and 2 diabetes. RESULTS: Overall, 34 instruments were identified, 32 PROMs and two PREMs. The most common instrument included outcomes related to quality of life at 44% (n = 15), followed by satisfaction (whether with treatment, device, and healthy habits) at 26% (n = 9). Furthermore, instruments regarding personal well-being accounted for 15% (n = 5). For instruments that measure experiences of persons with diabetes, there were two scales of symptoms, and one related to the attitude patients have toward the disease. CONCLUSIONS: Diabetes-specific validated instruments mainly focus on quality of life, education, and treatment, and sometimes overlap each other, in their subscales and assessment dimensions. Constructs such as cultural and religious beliefs, leisure, and work life may need more attention. There appears to be a gap in instruments to measure experiences of individuals who “live with diabetes” and seek to lead a “normal life.” SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s40271-021-00526-y. |
format | Online Article Text |
id | pubmed-8563512 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-85635122021-11-15 Patient-Reported Experience and Outcome Measures in People Living with Diabetes: A Scoping Review of Instruments Martin-Delgado, Jimmy Guilabert, Mercedes Mira-Solves, José Patient Scoping Review BACKGROUND: Diabetes mellitus is a global public health concern, with over 463 million people living with this chronic disease. Pathology complexity, management difficulty, and limited participation in care has resulted in healthcare systems seeking new strategies to engage people living with diabetes. Patient-reported experience measures (PREMs) and patient-reported outcome measures (PROMs) were developed to address the gap between the healthcare system expectation and patient preference. OBJECTIVE: This study aimed to review the existing literature on PREMs and PROMs specific to type 1 and 2 diabetes, and report the dimensions report the dimensions they have measured. METHODS: A scoping review was conducted from January 1985 to March 2020 of six databases, MEDLINE, EMBASE, PsycINFO, CINHAL, Scopus, and BiblioPro, to identify PREM and PROM instruments specific for type 1 and 2 diabetes. RESULTS: Overall, 34 instruments were identified, 32 PROMs and two PREMs. The most common instrument included outcomes related to quality of life at 44% (n = 15), followed by satisfaction (whether with treatment, device, and healthy habits) at 26% (n = 9). Furthermore, instruments regarding personal well-being accounted for 15% (n = 5). For instruments that measure experiences of persons with diabetes, there were two scales of symptoms, and one related to the attitude patients have toward the disease. CONCLUSIONS: Diabetes-specific validated instruments mainly focus on quality of life, education, and treatment, and sometimes overlap each other, in their subscales and assessment dimensions. Constructs such as cultural and religious beliefs, leisure, and work life may need more attention. There appears to be a gap in instruments to measure experiences of individuals who “live with diabetes” and seek to lead a “normal life.” SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s40271-021-00526-y. Springer International Publishing 2021-05-27 2021 /pmc/articles/PMC8563512/ /pubmed/34043215 http://dx.doi.org/10.1007/s40271-021-00526-y Text en © The Author(s) 2021 https://creativecommons.org/licenses/by-nc/4.0/Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Scoping Review Martin-Delgado, Jimmy Guilabert, Mercedes Mira-Solves, José Patient-Reported Experience and Outcome Measures in People Living with Diabetes: A Scoping Review of Instruments |
title | Patient-Reported Experience and Outcome Measures in People Living with Diabetes: A Scoping Review of Instruments |
title_full | Patient-Reported Experience and Outcome Measures in People Living with Diabetes: A Scoping Review of Instruments |
title_fullStr | Patient-Reported Experience and Outcome Measures in People Living with Diabetes: A Scoping Review of Instruments |
title_full_unstemmed | Patient-Reported Experience and Outcome Measures in People Living with Diabetes: A Scoping Review of Instruments |
title_short | Patient-Reported Experience and Outcome Measures in People Living with Diabetes: A Scoping Review of Instruments |
title_sort | patient-reported experience and outcome measures in people living with diabetes: a scoping review of instruments |
topic | Scoping Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8563512/ https://www.ncbi.nlm.nih.gov/pubmed/34043215 http://dx.doi.org/10.1007/s40271-021-00526-y |
work_keys_str_mv | AT martindelgadojimmy patientreportedexperienceandoutcomemeasuresinpeoplelivingwithdiabetesascopingreviewofinstruments AT guilabertmercedes patientreportedexperienceandoutcomemeasuresinpeoplelivingwithdiabetesascopingreviewofinstruments AT mirasolvesjose patientreportedexperienceandoutcomemeasuresinpeoplelivingwithdiabetesascopingreviewofinstruments |